Bio-guided discovery of antibacterial metabolites from Penicillium chrysogenum
Journal of Enzyme Inhibition and Medicinal Chemistry · 2025
DOI: 10.1080/14756366.2025.2547258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, 2025. Verfasst von Amira Mira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy and Pharmaceutical Chemistry, College of Dentistry and Pharmacy, Burayda Colleges, Buraydah, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Penicillium chrysogenum, Anti-Bacterial Agents, Gram-Negative Bacteria, Drug Discovery. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Prince Sattam bin Abdulaziz University.
Abstract (Originalsprache)
Bio-guided isolation from the Red Sea-derived Penicillium chrysogenum yielded two new metabolites, 15-deoxy-15-amino-citreohybridonol (6) and chrysogenotoxin (7), alongside five known compounds: emodin (1), chrysophanol (2), bis(2-ethylhexyl) phthalate (3), haenamindole (4), and citreorosein (5). Compound 6 exhibited broad-spectrum antibacterial activity against both Gram-positive (MIC: 0.31-0.62 μM; MBC: 0.31-0.62 μM) and Gram-negative bacteria (MIC: 0.15-1.25 μM; MBC: 0.62-2.5 μM). Compound 7 showed potent bactericidal activity against Gram-negative bacteria (MIC: 0.07-0.31 μM; MBC: 0.15-0.62 μM) with MBC/MIC ≤ 4, while compound 4 selectively inhibited S. pneumoniae (MIC: 0.31 μM; MBC: 0.62 μM). Compounds 4, 6, and 7 exhibited low cytotoxicity towards human intestinal epithelial cells (HIEC-6). Molecular docking studies targeting the NDM-1 β-lactamase identified compounds 4, 6, and 7 as potential inhibitors of New Delhi metallo-β-lactamase-1 (NDM-1). Molecular dynamics simulations confirmed the structural stability of 7 within the NDM-1 active site. Chrysogenotoxin (7) was suggested as a promising antibacterial candidate against antibiotic-resistant pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy and Pharmaceutical Chemistry, College of Dentistry and Pharmacy, Burayda Colleges, Buraydah, Kingdom of Saudi Arabia.
- Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Horus University, Damietta, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
ORCID-Profile: Amira Mira, Fatma M Abdel Bar, Ahmed I Foudah, Mohamed H Aboutaleb, Tarek S Ibrahim, Ahmed H E Hassan, Ashraf T Khalil
Förderung
- Prince Sattam bin Abdulaziz University
Zitieren
APA
Mira, A., Abdel Bar, F. M., Foudah, A. I., Aboutaleb, M. H., Ibrahim, T. S., Hassan, A. H. E., & Khalil, A. T. (2025). Bio-guided discovery of antibacterial metabolites from Penicillium chrysogenum. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2025.2547258
Vancouver
Mira A, Abdel Bar FM, Foudah AI, Aboutaleb MH, Ibrahim TS, Hassan AHE, et al. Bio-guided discovery of antibacterial metabolites from Penicillium chrysogenum. Journal of Enzyme Inhibition and Medicinal Chemistry. 2025. doi:10.1080/14756366.2025.2547258
BibTeX
@article{Mira2025,
author = {Mira, Amira and Abdel Bar, Fatma M and Foudah, Ahmed I and Aboutaleb, Mohamed H and Ibrahim, Tarek S and Hassan, Ahmed H E and Khalil, Ashraf T},
title = {Bio-guided discovery of antibacterial metabolites from Penicillium chrysogenum},
journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
year = {2025},
doi = {10.1080/14756366.2025.2547258}
}
EUVIMED